Press Release: Introduction of the Atera Spatial Analysis Instrument

Sanyo Trading Co., Ltd. (listed on the Tokyo Stock Exchange Prime Market), the parent company of KOTAI Biotechnologies, Inc., has published a press release announcing that we have introduced the “Atera” whole-transcriptome spatial analysis instrument, which is scheduled for release by the U.S.-based company 10x Genomics. We are currently preparing to begin offering services using this instrument to pharmaceutical companies and research institutions in Japan.

For more details, please refer to the press release published by Sanyo Trading Co., Ltd. below.
Sanyo Trading Release URL: https://www.sanyo-trading.co.jp/2026/07/29/kotai/

For more details regarding Atera, please refer to the 10x Genomics website below.
About Atera: https://www.10xgenomics.com/instruments/atera-instrument

If you are interested in our Atera contract services or would like further information, please feel free to contact us via the inquiry form below.
Inquiry Form: https://www.kotai-bio.com/service/contact/

Contact

KOTAI Biotechnologies, Inc.
Yokoi, General Manager, Administration Department
Tel: (072) 737-8903
Email: contact@kotai-bio.com
KOTAI Biotechnologies web site